Immunogenicity & Safety of Bio Farma's Measles-Rubella (MR) Vaccine in Indonesian Infants (Bridging Study)

Clinical trial NCT04183114 · COMPLETED

Trial details

NCT number: NCT04183114
Sponsor: PT Bio Farma
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Congenital Rubella Infection Measles

Start date: 2019-09-03
Primary completion: 2019-11-11
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.